Funding for this research was provided by:
Bristol-Myers Squibb (Unrestricted)
Article History
Received: 27 July 2018
Accepted: 19 October 2018
First Online: 9 November 2018
Compliance with ethical standards
:
: The first three authors have received funds from BMS. Eduardo Díaz-Rubio has a consulting/advisory role in Amgen, Bayer, Genómica, Servier and Merck and is Speaker in Servier and MSD. He has also received research funding from Roche, Merck-Serono, Amgen, Astra Zeneca and Sysmex. Carlos Camps has a consulting or advisory role in BMS, Bayer and Roche and is a speaker in Astra Zeneca. He has received research funding from BMS, Astra Zeneca and Sysmex.
: This research does not involve human participants and/or animals.
: For this type of study informed consent is not required.